BTI
RCUS icon

Blue Trust Inc’s Arcus Biosciences RCUS Stock Holding History

Blue Trust Inc’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-376
Closed -$5.73K – 2867
2024
Q3 		$5.73K Buy
376
+91
+32% +$1.44K ﹤0.01% 2361
2024
Q2 		$5.38K Buy
+285
New +$4.6K ﹤0.01% 2179
2024
Q1 		– Sell
-26
Closed – – 2610
2023
Q4 		$0 Sell
26
-474
-95% -$7.58K ﹤0.01% 2659
2023
Q3 		$10K Hold
500
– – ﹤0.01% 1417
2023
Q2 		$9K Hold
500
– – ﹤0.01% 1350
2023
Q1 		$10K Buy
+500
New +$9.56K ﹤0.01% 1608
2022
Q4 		– Sell
-40
Closed -$1K – 2420
2022
Q3 		$1K Buy
+40
New +$1.06K ﹤0.01% 1992

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Blue Trust Inc's RCUS Position: Q4 2024 in Review

Blue Trust Inc sold out of Arcus Biosciences (RCUS) in Q4 2024, closing a stake of 376 shares — an estimated $5.73K sold.

Blue Trust Inc first reported a position in RCUS in Q3 2022 and held it in 7 quarters. The position peaked at $10K in Q3 2023. 186 funds tracked by Wall St. Rank hold RCUS as of Q4 2024.

  • Blue Trust Inc reported no remaining Arcus Biosciences position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 376 Arcus Biosciences shares in Q4 2024, an estimated $5.73K.
  • Blue Trust Inc first reported a position in Arcus Biosciences in Q3 2022 and held it in 7 quarters.
  • Blue Trust Inc's Arcus Biosciences position peaked at $10K in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.